Improving survival for children with sickle cell disease: newborn screening is only the first step

Patrick T McGann1

  • 1Cincinnati Children's Hospital Medical Center , Cincinnati, Ohio, USA.

Insights

Newborn screening for sickle cell disease (SCD) in Brazil significantly improves survival rates for affected children. Early detection and comprehensive care are crucial for better pediatric health outcomes.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Sickle cell disease (SCD) is a significant global health concern, particularly in regions with high prevalence.
  • Newborn screening programs are essential for early detection and management of genetic disorders like SCD.
  • The implementation of comprehensive newborn screening in Minas Gerais, Brazil, aimed to address the challenges of SCD care.

Purpose of the Study:

  • To comment on the findings of Sabarense et al. regarding the survival of children with sickle cell disease.
  • To evaluate the effectiveness of the newborn screening program in Minas Gerais.
  • To highlight the impact of early detection and management on pediatric SCD outcomes.

Main Methods:

  • This is a commentary, not a primary research study.
  • It analyzes and discusses the results presented in the study by Sabarense et al.
  • Key aspects of the comprehensive newborn screening program and its impact on survival are examined.

Main Results:

  • The commentary underscores the positive impact of the newborn screening program on the survival of children with sickle cell disease.
  • Early diagnosis through screening leads to timely interventions, improving long-term prognosis.
  • The program demonstrates the feasibility and benefits of widespread SCD screening in a large Brazilian state.

Conclusions:

  • Comprehensive newborn screening for sickle cell disease is a highly effective public health strategy.
  • Continued investment and expansion of such programs are vital for reducing SCD-related mortality in children.
  • The Brazilian experience offers a valuable model for other countries aiming to improve care for children with SCD.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702